Tag Archives: U.S.

Staph Infections Drop, but Levels Still Worry U.S. Health Officials

Print this page TUESDAY, March 5, 2019 — Dangerous staph infections are declining in America, but they still pose a significant public health threat, a new report from the U.S. Centers for Disease Control and Prevention shows. “Today, we are talking about an infection that’s all too common, one of the leading causes of deadly… Read More »

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »